SCHEMBL4355055

SCHEMBL4355055

O=C1N=C(N2CCSCC2)SC1=Cc1cccc(C(F)(F)F)c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
MAPT P10636 4/20 0.57
KMT2A Q03164 4/20 0.57
HTT P42858 3/20 0.57
CISD1 Q9NZ45 2/20 0.51
TTR P02766 1/20 0.51
PIM1 P11309 1/20 0.51
PIM2 Q9P1W9 1/20 0.51
NPSR1 Q6W5P4 2/20 0.50
MAPK1 P28482 1/20 0.50
MDM2 Q00987 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
HPGD P15428 1/20 0.48
MEN1 O00255 3/20 0.47
ENPP2 Q13822 1/20 0.47
RAB9A P51151 1/20 0.46
MCHR1 Q99705 1/20 0.46
DCTPP1 Q9H773 1/20 0.46
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4355053 1.00 ALDH1A1 (0.57) ALDH1A1MAPTKMT2AHTTCISD1
SCHEMBL4354246 0.88 KMT2A (0.63) ALDH1A1MAPTKMT2AHTTCISD1
SCHEMBL4354242 0.88 KMT2A (0.63) ALDH1A1MAPTKMT2AHTTCISD1
Bromide SCHEMBL4356134 0.87 KMT2A (0.62) ALDH1A1MAPTKMT2AHTTCISD1
Bromide SCHEMBL4356131 0.87 KMT2A (0.62) ALDH1A1MAPTKMT2AHTTCISD1
SCHEMBL4351235 0.86 MAPT (0.63) ALDH1A1MAPTKMT2AHTTPIM1
SCHEMBL4351239 0.86 MAPT (0.63) ALDH1A1MAPTKMT2AHTTPIM1
SCHEMBL4352583 0.82 ALDH1A1 (0.80) ALDH1A1MAPTKMT2AHTTNPSR1
SCHEMBL4352578 0.82 ALDH1A1 (0.80) ALDH1A1MAPTKMT2AHTTNPSR1
SCHEMBL4350811 0.80 ALDH1A1 (0.58) ALDH1A1MAPTKMT2AHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
EP-1890695-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2008-02-27 EP claimed
WO-2006122777-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2006-11-23 WO claimed
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP disclosed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed
EP-1890695-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2008-02-27 EP disclosed
WO-2006122777-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 ALDH1A1 284/4885MAPT 1470/4885KMT2A 3923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.